Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma
Clinical trial NCT03503864 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03503864
- Sponsor
- Yang Li
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2023-08-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.